Clinical Trial Update: A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast Cancer

View source ↗

Summary

A completed clinical trial evaluating the safety and tolerability of Herceptin (trastuzumab) as adjuvant therapy for early breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer, Early Breast Cancer | Status: COMPLETED